Navigation Links
HealthAware Introduces Its VascularAware Cardiovascular Disease Module
Date:2/20/2008

DENVER, Feb. 20 /PRNewswire/ -- HealthAware, a leading supplier of innovative services to healthcare providers, announced today the launch of VascularAware, the newest disease module in its Cardiovascular Program. VascularAware is designed to help people who may be at risk for Peripheral Artery Disease (PAD), which affects nearly 10 million adult Americans, according to the American Heart Association.

Development of the VascularAware disease module extends the Company's mission of promoting early detection and prevention of disease.

"PAD affects eight to 12 million people in the U.S., and represents a significant growth market for hospitals," says Greg Gossett, HealthAware President. "According to the Society of Interventional Radiology, PAD impacts 12 to 20 percent of those over age 65, and nearly 20 percent of all men and women age 70 and older."

Mr. Gossett goes on to say, "Through VascularAware, we will be able to better help hospitals attain their goals, while also helping them to increase their visibility and goodwill within their communities."

PAD is a form of atherosclerosis. The most common type of PAD is the hardening and narrowing of arteries that are caused by the gradual buildup of fatty deposits and additional substances. The result is restricted blood flow, mainly in the arteries that lead to the legs and extremities.

Many people with PAD have no symptoms, which is one reason why it is important to screen for this disease through VascularAware. About one third of those with PAD have symptoms in the form of leg pain, cramping, fatigue or other discomfort in the calves or hips when they are walking or engaged in other activity.

However, these symptoms typically will subside when they rest. Because of this, PAD can often go undiagnosed during its early stages because people mistake their symptoms for a form of arthritis or as simply a sign of aging.

By the time people with PAD begin to suffer from s
'/>"/>

SOURCE HealthAware
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
2. SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
3. Biomatrica Introduces SampleWare(R) Version 3.0 Software for Laboratory Sample Management
4. Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
5. Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
6. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
7. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
8. Finesse Introduces TruBio(TM) IOQ
9. Nikon Instruments Introduces NIS-Elements Software for Eclipse Ti-E Live-Cell Applications
10. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
11. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that ... Matsuda, Horiba Scientific, have organized a session on nanotechnology ... JASIS , Asia’s largest analytical and scientific instruments show, ... Japan. , The four speakers in this U.S. ... Molecules to Single Cells” will present their use of ...
(Date:8/29/2014)... MA (PRWEB) August 29, 2014 A ... in the biotech start-up dense realm of Boston-Cambridge, is ... and able investors. James Sherley, the Director of Boston’s ... increasing the local and national visibility of his company ... September 2013. , In addition to a social media ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and ... 150 ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for ... owners and USDA-GIPSA inspection agencies that have a need to ... place in a matter of minutes with nothing but our ... feed and grain before accepting it, but they no longer ...
(Date:8/28/2014)... Aug. 28, 2014  Next month, executives from clinical trial ... industry events beginning with Patient-Centered Clinical Trials 2014 , ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits of ... of tactics – from media to mobile apps – can ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2
... Conference on Lung Cancer in Seoul, Korea, ... Inc.,(AMEX: YMI , TSX: YM, AIM: YMBA), ... products for patients worldwide,today announced positive preliminary results ... part of a Phase I/II trial of nimotuzumab ...
... the Biotech,Industry, Bank of America Investment, and UBS Global Life Sciences ... ... Sept. 4 Trubion Pharmaceuticals,Inc. (Nasdaq: TRBN ) announced today ... will present an overview,of the company at three September investor conferences: ...
... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical ... cancer and,hepatitis C virus (HCV) infection, today announced that ... ended July 31, 2007 on September,10, 2007, and will ... at 11:30 a.m. EDT on the same day. ...
Cached Biology Technology:YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 2YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 3YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 4YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 5Trubion Pharmaceuticals to Present at Upcoming Investor Conferences 2Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results 2
(Date:8/28/2014)... , Aug. 28, 2014  Privacy Advocate and Senior ... Jennifer Lynch , joins the lineup of biometric and ... annual Biometrics UnPlugged Executive Summit in Tampa, ... Previously announced speakers include Steven Rahman, Director, Technology and ... Sector at Experian. The theme of this year,s event ...
(Date:8/28/2014)... the most commonly diagnosed learning disability in the ... occurs when the regions of the brain that ... use of non-invasive functional neuroimaging tools has helped ... However, most prior work has focused on only ... gap in our understanding of how multiple brain ...
(Date:8/28/2014)... Alaska totaled 515 million board feet in volume in ... than 10 percent compared to the first quarter of ... reported today. During this same period, West coast lumber ... feet. , The total value of these log exports ... in the same quarter, while the total value of ...
Breaking Biology News(10 mins):Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2Dyslexic readers have disrupted network connections in the brain 2West coast log exports up, lumber exports down in second quarter of 2014 2
... sense of touch, researchers have shown. A study, by Dr ... at the University of Surrey, has found that Bacillus mycoides ... forces and curvature in the medium on which it,s growing. ... as revealed in the journal PLOS ONE , could signal ...
... in German . ... More precise tests may allow allergy sufferers more freedom of food ... out by the Helmholtz Centre for Environmental Research (UFZ), the University ... examined patients with a Nile perch allergy. Being allergic to Nile ...
... - December 10, 2013 Researchers at the Icahn ... strain of influenza the virus that causes the flu ... even after it develops resistance to antiviral medications. The finding was ... Nature Communications . It is not uncommon for ...
Cached Biology News:The garden microbe with a sense of touch 2Each food fish can cause specific allergies 2Each food fish can cause specific allergies 3Mount Sinai researchers say new strain of bird flu packs a punch even after becoming drug-resistant 2